Back
Protagonist Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
PTGX
Protagonist Therapeutics, Inc.
Last Price:
$86.04
Seasonality Move:
29.24%
7 Day Trial
ALL ACCESS PASS
$
7
Protagonist Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Protagonist Therapeutics, Inc. has on average historically risen by 47.9% based on the past 9 years of stock performance.
-
Protagonist Therapeutics, Inc. has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Protagonist Therapeutics, Inc. Stock Undervalued?The current Protagonist Therapeutics, Inc. [PTGX] share price is $86.05. The Score for PTGX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Protagonist Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Protagonist Therapeutics, Inc. has on average historically risen by 47.9% based on the past 9 years of stock performance.
Protagonist Therapeutics, Inc. Stock Rating
Sell
39
Protagonist Therapeutics, Inc. (PTGX)
is a Sell
Is Protagonist Therapeutics, Inc. overpriced?
-
Protagonist Therapeutics, Inc. has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Protagonist Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protagonist-inc.com
52-Week Data
52-Week High:
96.54
52-Week Low:
33.70
Prediction Charts
Market Cap:
5.4B
Price in USD:
86.05
Volume:
1.7M
Beta:
1.93
Technical Analysis
SMA50:
83.33
SMA100:
71.32
SMA200:
60.62
52-Wk Change:
117.63%
Stock Predictions
-
Is Protagonist Therapeutics, Inc. stock public?Yes, Protagonist Therapeutics, Inc. is a publicly traded company.
-
What is the Protagonist Therapeutics, Inc. stock quote today?The Protagonist Therapeutics, Inc. stock price is 86.05 USD today.
-
How to buy Protagonist Therapeutics, Inc. stock online?You can buy Protagonist Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 85.75 | 84.65 | 86.39 | 83.52 |
| Dec-3 | 85.43 | 86.07 | 87.10 | 84.73 |
| Dec-4 | 86.07 | 87.33 | 88.10 | 85.13 |
| Dec-5 | 87.96 | 89.65 | 90.18 | 87.54 |
| Dec-8 | 90.94 | 90.25 | 91.89 | 89.51 |
| Dec-9 | 89.73 | 88.56 | 92.80 | 88.30 |
| Dec-10 | 88.56 | 91.38 | 91.96 | 88.34 |
| Dec-11 | 92.01 | 92.25 | 93.07 | 91.07 |
| Dec-12 | 92.72 | 95.35 | 95.39 | 91.70 |
| Dec-15 | 95.41 | 94.79 | 96.54 | 94.17 |
| Dec-16 | 93.93 | 91.54 | 94.54 | 90.18 |
| Dec-17 | 91.41 | 89.34 | 92.54 | 88.38 |
| Dec-18 | 89.35 | 85.79 | 90.02 | 84.11 |
| Dec-19 | 86.58 | 86.05 | 87.73 | 84.81 |
Protagonist Therapeutics, Inc. Earnings
Protagonist Therapeutics, Inc. Earnings Report: Per Share Protagonist Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Protagonist Therapeutics, Inc. Forecast Revenue Growth
Protagonist Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $1.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.50 per share, and an increase next year of $2.93 per share.
* Protagonist Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.